New Biotech IPO Dropped a Unicorn-Sized Value on Its First Day

(Bloomberg) -- Moderna Inc.’s decision to go public as the latest biotechnology unicorn garnered a lot of excitement on Wall Street -- and then it fell flat.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.